Knopf A, Parodi K, Bortfeld T, Shih H A, Paganetti H
Department of Radiation Oncology, MGH and Harvard Medical School, Boston, MA 02114, USA.
Phys Med Biol. 2009 Jul 21;54(14):4477-95. doi: 10.1088/0031-9155/54/14/008. Epub 2009 Jun 26.
The clinical use of offline positron emission tomography/computed tomography (PET/CT) scans for proton range verification is currently under investigation at the Massachusetts General Hospital (MGH). Validation is achieved by comparing measured activity distributions, acquired in patients after receiving one fraction of proton irradiation, with corresponding Monte Carlo (MC) simulated distributions. Deviations between measured and simulated activity distributions can either reflect errors during the treatment chain from planning to delivery or they can be caused by various inherent challenges of the offline PET/CT verification method. We performed a systematic analysis to assess the impact of the following aspects on the feasibility and accuracy of the offline PET/CT method: (1) biological washout processes, (2) patient motion, (3) Hounsfield unit (HU) based tissue classification for the simulation of the activity distributions and (4) tumor site specific aspects. It was found that the spatial reproducibility of the measured activity distributions is within 1 mm. However, the feasibility of range verification is restricted to a limited amount of positions and tumor sites. Washout effects introduce discrepancies between the measured and simulated ranges of about 4 mm at positions where the proton beam stops in soft tissue. Motion causes spatial deviations of up to 3 cm between measured and simulated activity distributions in abdominopelvic tumor cases. In these later cases, the MC simulated activity distributions were found to be limited to about 35% accuracy in absolute values and about 2 mm in spatial accuracy depending on the correlativity of HU into the physical and biological parameters of the irradiated tissue. Besides, for further specific tumor locations, the beam arrangement, the limited accuracy of rigid co-registration and organ movements can prevent the success of PET/CT range verification. All the addressed factors explain why the proton beam range can only be verified within an accuracy of 1-2 mm in low-perfused bony structures of head and neck patients for which an accurate co-registration of predominant bony anatomy is possible, as shown previously. However, most of the limitations of the current approach are conquerable. By implementing technological and methodological improvements like the use of in-room PET scanners, PET measurements could soon be used to provide proton range verification in clinical routine.
马萨诸塞州总医院(MGH)目前正在研究离线正电子发射断层扫描/计算机断层扫描(PET/CT)扫描在质子射程验证中的临床应用。通过将接受一次质子照射后患者体内获取的测量活度分布与相应的蒙特卡罗(MC)模拟分布进行比较来实现验证。测量和模拟活度分布之间的偏差既可能反映从计划到交付的治疗链中的误差,也可能由离线PET/CT验证方法的各种固有挑战引起。我们进行了系统分析,以评估以下方面对离线PET/CT方法的可行性和准确性的影响:(1)生物洗脱过程,(2)患者运动,(3)基于亨氏单位(HU)的组织分类以模拟活度分布,以及(4)肿瘤部位特定方面。结果发现,测量活度分布的空间再现性在1毫米以内。然而,射程验证的可行性仅限于有限数量的位置和肿瘤部位。洗脱效应在质子束在软组织中停止的位置导致测量和模拟射程之间出现约4毫米的差异。在腹部盆腔肿瘤病例中,运动导致测量和模拟活度分布之间的空间偏差高达3厘米。在这些后期病例中,根据HU与受照射组织的物理和生物学参数的相关性,发现MC模拟活度分布的绝对值精度约为35%,空间精度约为2毫米。此外,对于进一步的特定肿瘤位置,射束排列、刚性配准的有限精度和器官运动可能会妨碍PET/CT射程验证的成功。所有上述因素解释了为什么在头颈部患者低灌注的骨性结构中,质子束射程只能在1-2毫米的精度内得到验证,如先前所示,因为在这些部位可以对主要的骨性解剖结构进行精确配准。然而,当前方法的大多数局限性是可以克服的。通过实施技术和方法上的改进,如使用室内PET扫描仪,PET测量可能很快用于在临床常规中提供质子射程验证。